Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice-Reference-Cited by-同舟云学术

Active immunization with norovirus P particle-based amyloid-β chimeric protein vaccine induces high titers of anti-Aβ antibodies in mice

Published:2019-02-12 Issue:1 Volume:20 Page:
ISSN:1471-2172
Container-title:BMC Immunology
language:en
Short-container-title:BMC Immunol

Author:

Yang Ping,Guo Yongqing,Sun Yao,Yu Bin,Zhang Haihong,Wu Jiaxin,Yu Xianghui,Wu Hui^ORCID,Kong Wei

Funder

Science & Technology Development Plan of Jilin Province

Publisher

Springer Science and Business Media LLC

Subject

Immunology

Link

http://link.springer.com/content/pdf/10.1186/s12865-019-0289-9.pdf

Reference59 articles.

1. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368(9533):387–403.

2. Herrera AC, Prince M, Knapp M, Karagiannidou M, Guerchet M. World Alzheimer report 2016: improving healthcare for people with dementia. Coverage: Quality and costs now and in the future; 2016.

3. Catindig JA, Venketasubramanian N, Ikram MK, Chen C. Epidemiology of dementia in Asia: insights on prevalence, trends and novel risk factors. J Neurol Sci. 2012;321(1–2):11–6.

4. Niu H, I Á-Á, Guillén-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis. Neurologia. 2016;32(8):523–32.

5. Brown L, Hansnata E, Hai AL. Economic cost of dementia in Australia 2016–2056; 2017.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NFκBp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats;PLOS ONE;2022-03-29

2. Targeted drug delivery systems to control neuroinflammation in central nervous system disorders;Journal of Drug Delivery Science and Technology;2021-12

3. Peptide-Based Vaccines for Neurodegenerative Diseases: Recent Endeavors and Future Perspectives;Vaccines;2021-11-04

4. Immunotherapies for Neurodegenerative Diseases;Frontiers in Neurology;2021-06-07

5. Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer’s Disease: Are Immunotherapies Effective or Off-Target?;The Neuroscientist;2021-02-03